CAR-T Therapy Leads to Myasthenia Gravis Improvements

(MedPage Today) — SAN FRANCISCO — Descartes-08, an autologous T cell therapy directed by B-cell maturation antigen (BCMA) and chimeric antigen receptor (CAR) mRNA, led to sustained responses in generalized myasthenia gravis (GMG), a phase IIb trial…